Heerma Peter Insider Trading -- Recent SEC Form 4 Transactions

Heerma Peter (CIK 1789617) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-15). Recent activity: Buy TVTX (14,000 shares), Sell TVTX (7,215 shares), Buy TVTX (26,120 shares), Sell TVTX (7,310 shares), Sell TVTX (4,980 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-04-15Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERBuy14,000$0
2026-04-15Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell7,215$302,516
2026-02-03Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERBuy26,120$0
2026-02-03Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell7,310$234,797
2025-12-29Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell4,980$199,200
2025-11-04Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell5,591$195,685
2025-11-04Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell1,078$0
2025-10-30Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell2,662$79,860
2025-09-24Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell891$0
2025-05-05Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERBuy4,920$0
2025-05-05Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell1,771$37,280
2025-02-12Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERBuy8,000$0
2025-02-12Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell3,074$76,850
2025-02-12Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell2,568$60,425
2025-02-04Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERBuy21,500$0
2025-02-04Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell5,166$103,940
2025-01-23Travere Therapeutics, Inc. (TVTX)CHIEF COMMERCIAL OFFICERSell1,584$30,001

Source: SEC Form 4 filings · as of 2026-04-15